Author Archives: admin
CAS-AM: Week 2, Day 3
CAS-AM: Shaping the Future of Thrombosis Care Exciting day in training the new antithrombotic management experts: Portfolio Discussions with faculty. Following the first training week, participants worked on their CAS-AM portfolios reflecting and providing evidence of the development of antithrombotic … Continue reading
CAS-AM: Week 2, Day 2
CAS-AM: Shaping the Future of Thrombosis Care With a focus on “PE in elderly subject with multiple CV risk factors”, the 2nd day of the second CAS-AM course week started with the post-discussion, followed by a combined lecture on the … Continue reading
CAS-AM: Week 2, Day 1
CAS-AM: Shaping the Future of Thrombosis Care After a long summer in which the participants completed their portfolio, it’s time for the second CAS-AM course week. The first day started with a combined lecture on DOAC pharmokinetics and drug-drug interactions … Continue reading
Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease.
Kremers BMM, Posma JN, Heitmeier S, Glunz J, Ten Cate H, Pallares Robles A, Daemen JHC, Ten Cate-Hoek AJ, Mees BME, Spronk HMH. Sci Rep. 2022 Nov 1;12(1):18388. PMID: 36319844 Peripheral artery disease (PAD) patients have an increased cardiovascular risk … Continue reading
Posted in publications
Leave a comment
Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism.
Baidildinova G, Ten Cate V, Nagler M, Panova-Noeva M, Rapp S, Köck T, Prochaska JH, Heitmeier S, Gerdes C, Schwers S, Konstantinides SV, Münzel T, Espinola-Klein C, Lackner KJ, Spronk HMN, Ten Cate H, van der Meijden PEJ, Leineweber K, … Continue reading
Posted in publications
Leave a comment
Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort.
an de Berg TW, Mulder MMG, Alnima T, Nagy M, van Oerle R, Beckers EAM, Hackeng TM, Hulshof AM, Sels JEM, Henskens YMC, van der Horst ICC, Ten Cate H, Spronk HMH, van Bussel BCT; MaastrICCht Collaborators. Front Cardiovasc Med. … Continue reading
Posted in publications
Leave a comment
Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial.
Willems LH, Thijssen DHJ, Groh LA, Kooijman NI, Ten Cate H, Spronk HMH, Donders ART, van der Vijver-Coppen RJ, van Hoek F, Nagy M, Reijnen MMPJ, Warlé MC. Front Cardiovasc Med. 2022 Oct 6;9:979819. PMID: 36277757 Objective: Dual pathway inhibition … Continue reading
Posted in publications
Leave a comment
Vitamin K antagonist use induces calcification and atherosclerotic plaque progression resulting in increased hypercoagulability.
van Gorp RH, Baaten CCFMJ, Habibi A, Jaminon AMG, Peeters FECM, Leenders P, Crijns HJGMC, Heemskerk JWM, Reutelingsperger CP, Spronk HM, Schurgers LJ. Eur Heart J Open. 2021 Aug 6;1(2):oeab017. PMID: 35919270 Aims: Vascular calcification is a hallmark of atherosclerotic … Continue reading
Posted in publications
Leave a comment
EPCR-PAR1 biased signaling regulates perfusion recovery and neovascularization in peripheral ischemia.
Bochenek ML, Gogiraju R, Großmann S, Krug J, Orth J, Reyda S, Georgiadis GS, Spronk HM, Konstantinides S, Münzel T, Griffin JH, Wild P, Espinola-Klein C, Ruf W, Schäfer K. JCI Insight. 2022 Jul 22;7(14):e157701. PMID: 35700057 Blood clot formation … Continue reading
Posted in publications
Leave a comment
Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation.
Nguyen BO, Weberndorfer V, Crijns HJ, Geelhoed B, Ten Cate H, Spronk H, Kroon A, De With R, Al-Jazairi M, Maass AH, Blaauw Y, Tieleman RG, Hemels MEW, Luermans J, de Groot J, Allaart CP, Elvan A, De Melis M, … Continue reading
Posted in publications
Leave a comment